Skip to main content

Exosens secures major long-term contract with BROLIS to supply 17 000 high-performance image intensifier tubes for the Czech Armed Forces

EXOSENS SECURES MAJOR LONG-TERM CONTRACT WITH BROLIS TO SUPPLY 17 000 HIGH-PERFORMANCE IMAGE INTENSIFIER TUBES FOR THE CZECH ARMED FORCES

  • Exosens has secured a major contract with BROLIS to supply approximately 17,000 high-performance image intensifier tubes for the Czech Armed Forces through 2032
  • This represents the largest procurement of image intensifier tubes ever undertaken by the Czech Republic, underscoring the field-proven operational performance, reliability, and quality of Exosens’ advanced night vision technologies
  • This new multi-year order also demonstrates the mission-critical role of night vision capabilities for dismounted soldiers in modern conflicts
  • The contract further strengthens Exosens’ position as a trusted, ITAR-free supplier to NATO armed forces while contributing to Europe’s strategic autonomy in defense

Press release, Mérignac (France), June 29, 2026 – Exosens (EXENS; FR001400Q9V2), a high-tech company specializing in mission- and performance-critical amplification, detection, and imaging technologies, today announces it has secured a major long-term contract with BROLIS to supply approximately 17,000 image intensifier tubes for the Czech Armed Forces.

Under the agreement, Exosens will deliver its high-performance image intensifier tubes to BROLIS through 2032, supporting the modernization of the Czech Armed Forces’ night vision capabilities while providing the Group with long-term revenue visibility.

This program represents the largest procurement of image intensifier tubes ever undertaken by the Czech Republic, demonstrating the field-proven operational performance, reliability and quality of Exosens’ advanced night vision technologies. It further reinforces the Group’s position as a trusted supplier of ITAR-free, mission-critical night vision components to NATO armed forces, as well as leading defense system integrators.

The contract also strengthens the European Defense Technological and Industrial Base by ensuring the supply of European-made critical components for next-generation night vision systems, in line with Europe’s priorities on strategic autonomy and defense industrial readiness.

“This contract marks an important milestone for Exosens. It reflects the confidence placed in the field-proven operational performance, reliability and quality of our advanced image intensifier technology and further strengthens our position as a trusted, ITAR-free partner to NATO armed forces. Together with BROLIS, we are proud to contribute to enhancing the operational capabilities of the Czech Armed Forces while supporting Europe’s strategic autonomy through a resilient and sovereign European Defense Technological and Industrial Base”, said Jérôme Cerisier, Chief Executive Officer of Exosens.

This contract further strengthens Exosens’ leadership in advanced night vision technologies and demonstrates the Group’s ability to secure large-scale, long-term defense programmes in a market supported by sustained investment in defense modernization across Europe and NATO countries.

Next financial event

  • 28/07/2026: H1 2026 results (before market opening).

About Exosens

Exosens is a high‐tech company, with more than 85 years of experience in the innovation, development, manufacturing and sale of high‐end electro‐optical technologies in the field of amplification, detection and imaging. Today, it offers its customers detection components and solutions such as advanced cameras, neutron and gamma detectors, instrument detectors and light intensifier tubes. This allows Exosens to respond to complex issues in extremely demanding environments by offering tailor-made solutions to its customers. Thanks to its sustained investments, Exosens is internationally recognized as a major innovator in optoelectronics, with production and R&D carried out on 12 sites, in Europe and North America, and with over 2,000 employees. Exosens is listed on compartment A of Euronext Paris regulated market (Ticker: EXENS; ISIN: FR001400Q9V2). Exosens is a member of Euronext Tech Leaders segment and is also included in several indices, including SBF 120, CAC All-Tradable, CAC Mid 60, FTSE Total Cap and MSCI France Small Cap. For more information: www.exosens.com.

Investor Relations

Laurent Sfaxi, l.sfaxi@exosens.com

Media Relations

Brunswick Group, exosens@brunswickgroup.com

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.